Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

Conditions: Focal Epilepsy Interventions: Drug: BHV-7000; Drug: BHV-7000; Drug: Placebo Sponsors: Biohaven Therapeutics Ltd. Not yet recruiting

Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials